| Literature DB >> 23467190 |
Kiran Kandukurti1, Jianlan Sun, Rocco Venuto.
Abstract
We report a 42-year-old woman with underlying hypertension, mild renal dysfunction and proteinuria who presented as an obstetric emergency with uncontrolled hypertension and nephrotic syndrome. The rapid deterioration in her kidney function and worsening of her symptoms led to an urgent termination of her twin pregnancy. Although a clinical improvement was noticed within 10 days, the persistently elevated serum creatinine required further evaluation. A kidney biopsy showed changes consistent with acute tubular necrosis and resolving preeclampsia superimposed on focal segmental glomerulosclerosis and hypertensive kidney disease. The importance of a kidney biopsy in confirming clinical suspicions and determining patient prognosis is emphasized.Entities:
Keywords: Acute tubular necrosis; Focal segmental glomerulosclerosis; Hypertension; Preeclampsia
Year: 2013 PMID: 23467190 PMCID: PMC3573803 DOI: 10.1159/000346862
Source DB: PubMed Journal: Case Rep Nephrol Urol ISSN: 1664-5510
Fig. 1Multiple pathologies in a single kidney biopsy. a Segmental sclerosis in a glomerulus. An increased paucicellular matrix, hyalinosis, endocapillary foam cells and wrinkled basement membrane (single arrow) are shown. Periodic acid-Schiff stain. ×200. b Superimposed preeclampsia. The glomerulus shows a ‘bloodless’ appearance with a swelling of the capillary endothelial cells and occluded or narrowed lumens, i.e. endotheliosis (single arrow). Mild vacuolation is noted in some endothelial cytoplasm. Hematoxylin and eosin stain. ×400. c Hypertension. The interlobular artery shows thickening of the wall with subintimal fibrosis, consistent with hypertensive disease (single arrow). Gomori trichrome stain. ×400. d Acute tubular necrosis. There is thinning of the tubular epithelium (single arrow) with loss of the nuclei, suggesting coagulative necrosis, and occasional mitotic figures (double arrows) can be seen. Hematoxylin and eosin stain. ×400. e Focal segmental glomerulosclerosis. A marked foot process effacement in a non-sclerotic capillary loop without electron-dense deposits (single arrows). Electron micrograph. f Focal segmental glomerulosclerosis. Granular staining of C3 is noted in the glomerulus (single arrows). Immunoflourescence. ×400.
Relevant laboratory investigations before the kidney biopsy
| Parameter | Value |
|---|---|
| Qualitative urinalysis | Sp.gr 1.020, 3+ protein, 3+ blood |
| Urine total protein, mg/day | 11,610 |
| Platelet count, ×109/l | 192 |
| Serum uric acid, mg/dl | 7.4 |
| ALT, U/l | 15 |
| AST, U/l | 24 |
| ALP, U/l | 105 |
| Total bilirubin, mg/dl | 0.8 |
| Serum albumin, g/dl | 0.9 |
| Lipid profile, mg/dl | TC 449; LDL-C 291; HDL-C 62; TG 848 |
| C3, g/l | 2.33 |
| C4, g/l | 0.45 |
| ANA, ANCA, anti GBM, anti ds DNA antibodies | Negative |
| Urine electrophoresis | Whole IgG and IgA detected |
| Urine for free light chains | Interference with free light chain determination noted due to whole immunoglobulins |
Conversion factors for units: uric acid in mg/dl to µmol/l, ×59.48; total bilirubin in mg/dl to µmol/l, ×17.1; albumin in g/dl to g/l, ×10; total serum cholesterol in mg/dl to mmol/l, ×0.02586; low-density lipoprotein cholesterol in mg/dl to mmol/l, ×0.02586; high-density lipoprotein cholesterol in mg/dl to mmol/l, ×0.02586; triglycerides in mg/dl to mmol/l, ×0.01129; no conversion necessary for platelets in ×109/l and ×103/µl. Sp.gr = Specific gravity; ALT = alanine aminotransferase; AST = aspartate aminotransferase; ALP = alkaline phosphatase; TC = total cholesterol; LDL-C = low-density lipoprotein cholesterol; HDL-C = high-density lipoprotein cholesterol; TG = triglycerides; C3 and C4 = complements 3 and 4; ANA = antinuclear antibody; ANCA = antineutrophil cytoplasmic antibody; GBM = glomerular basement membrane; ds DNA = double-stranded DNA; Ig = immunoglobulin.
Fig. 2Trends in serum creatinine and serum albumin levels over a period of approximately 6.5 years (August 2004–March 2011).
Fig. 3Trends in urine random protein/creatinine ratio over a period of 2 months (February–March 2011).